\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
ProgrammesThe Directorate-General for Climate Action (DG CLIMA), and the European Climate, Infrastructure, and Environment Executive Agency (CINEA) are organising this years’ Cleantech Conference: ‘Driving Sustainable Innovation’.
Recognising the clear need to accelerate the decarbonisation of Europe’s industrial sectors, this conference will explore pathways for supporting European manufacturing of cleantech devices and their components, especially for renewable energy technologies, batteries, electrolysers, and heat-pumps. The goal is to promote collaboration, facilitate knowledge sharing, and promote dialogue among stakeholders. This conference will gather high-level representatives of EU Institutions, stakeholders, and investors, as well as representatives from projects already supported by the EU Innovation Fund.
The deadline to register for in-person attendance is 31 March 31st .
Link to registration and preliminary programme.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
